Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study
- Resource Type
- Article
- Source
- The Lancet Respiratory Medicine; January 2023, Vol. 11 Issue: 1 p87-96, 10p
- Subject
- Language
- ISSN
- 22132600; 22132619